A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase.

Weinreb, Neal

A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase. [electronic resource] - American journal of hematology Dec 2008 - 890-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.21280 doi


Adolescent
Adult
Child
Dose-Response Relationship, Drug
Female
Gaucher Disease--drug therapy
Genotype
Glucosylceramidase--administration & dosage
Humans
Longitudinal Studies
Male
Middle Aged
Recombinant Proteins--administration & dosage
Registries
Retrospective Studies
Young Adult